Therac-25

Therac-25 was a computer-controlled radiation therapy machine, developed and manufactured by the Atomic Energy of Canada Limited (AECL) in 1982, following the earlier Therac-6 and Therac-20 models.
Overview[edit]
The Therac-25 was a sophisticated machine designed to provide radiation treatment for cancer patients. It could deliver two types of radiation: direct high-energy electron beams (up to 25 MeV) and X-rays produced by directing the electron beam onto a metal target. The machine was controlled by a computer that allowed the operator to select the type and intensity of radiation according to the specific treatment plan for each patient.
Development and Production[edit]
The development of the Therac-25 was a significant step forward in radiation therapy technology. Unlike its predecessors, the Therac-6 and Therac-20, which were developed in collaboration with French companies, the Therac-25 was fully designed and manufactured by AECL.
Safety Incidents[edit]
While the Therac-25 was a technological advancement, it was also associated with a series of safety incidents in which patients received massive overdoses of radiation. These accidents, which occurred between 1985 and 1987, were due to software errors that allowed the machine to deliver extremely high doses of radiation.
These incidents led to extensive investigations, resulting in significant changes in the standards and regulations for the development and use of medical software devices.
Legacy[edit]
Despite the safety issues associated with the Therac-25, the lessons learned from its use have had a profound impact on the fields of radiation therapy and medical device software development. It has led to a greater emphasis on software testing, risk assessment, and the importance of incorporating fail-safe mechanisms in medical devices.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
